Literature DB >> 11705951

Host response to infection: the role of CpG DNA in induction of cyclooxygenase 2 and nitric oxide synthase 2 in murine macrophages.

D K Ghosh1, M A Misukonis, C Reich, D S Pisetsky, J B Weinberg.   

Abstract

Depending on sequence, bacterial and synthetic DNAs can activate the host immune system and influence the host response to infection. The purpose of this study was to determine the abilities of various phosphorothioate oligonucleotides with cytosine-guanosine-containing motifs (CpG DNA) to activate macrophages to produce nitric oxide (NO) and prostaglandin E(2) (PGE(2)) and to induce expression of NO synthase 2 (NOS2) and cyclooxygenase 2 (COX2). As little as 0.3 microg of CpG DNA/ml increased NO and PGE(2) production in a dose- and time-dependent fashion in cells of the mouse macrophage cell line J774. NO and PGE(2) production was noted by 4 to 8 h after initiation of cultures with the CpG DNA, with the kinetics of NO production induced by CpG DNA being comparable to that induced by a combination of lipopolysaccharide and gamma interferon. CpG DNA-treated J774 cells showed enhanced expression of NOS2 and COX2 proteins as determined by immunoblotting, with the relative potencies of the CpG DNAs generally corresponding to those noted for the induction of NO and PGE(2) production as well as to those noted for the induction of interleukin-6 (IL-6), IL-12, and tumor necrosis factor. Extracts from CpG DNA-treated cells converted L-arginine to L-citrulline, but the NOS inhibitor N(G)-monomethyl-L-arginine (NMMA) inhibited this reaction. The COX2-specific inhibitor NS398 inhibited CpG DNA-induced PGE(2) production and inhibited NO production to various degrees. The NOS inhibitors NMMA, 1400W, and N-iminoethyl-L-lysine effectively blocked NO production and increased the production of PGE(2) in a dose-dependent fashion. Thus, analogues of microbial DNA (i.e., CpG DNA) activate mouse macrophage lineage cells for the expression of NOS2 and COX2, with the production of NO and that of PGE(2) occurring in an interdependent manner.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11705951      PMCID: PMC98865          DOI: 10.1128/IAI.69.12.7703-7710.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

Review 1.  Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides.

Authors:  A M Krieg
Journal:  Biochim Biophys Acta       Date:  1999-12-10

2.  The features of arthritis induced by CpG motifs in bacterial DNA.

Authors:  G M Deng; A Tarkowski
Journal:  Arthritis Rheum       Date:  2000-02

3.  Nitric oxide activates cyclooxygenase enzymes.

Authors:  D Salvemini; T P Misko; J L Masferrer; K Seibert; M G Currie; P Needleman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

4.  Regulation by prostaglandin E2 of cytokine-elicited nitric oxide synthesis in rat liver macrophages.

Authors:  T Gaillard; A Mülsch; H Klein; K Decker
Journal:  Biol Chem Hoppe Seyler       Date:  1992-09

5.  Inducible nitric oxide synthase from a rat alveolar macrophage cell line is inhibited by nitric oxide.

Authors:  J M Griscavage; N E Rogers; M P Sherman; L J Ignarro
Journal:  J Immunol       Date:  1993-12-01       Impact factor: 5.422

6.  Nitric oxide production from macrophages is regulated by arachidonic acid metabolites.

Authors:  Y Imai; H Kolb; V Burkart
Journal:  Biochem Biophys Res Commun       Date:  1993-11-30       Impact factor: 3.575

7.  Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin-6 by rat Kupffer cells.

Authors:  J Stadler; B G Harbrecht; M Di Silvio; R D Curran; M L Jordan; R L Simmons; T R Billiar
Journal:  J Leukoc Biol       Date:  1993-02       Impact factor: 4.962

8.  Modulation of the induction of nitric oxide synthase by eicosanoids in the murine macrophage cell line J774.

Authors:  P Marotta; L Sautebin; M Di Rosa
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

9.  Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation.

Authors:  J R Vane; J A Mitchell; I Appleton; A Tomlinson; D Bishop-Bailey; J Croxtall; D A Willoughby
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

10.  The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine.

Authors:  J B Weinberg; D L Granger; D S Pisetsky; M F Seldin; M A Misukonis; S N Mason; A M Pippen; P Ruiz; E R Wood; G S Gilkeson
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

View more
  13 in total

1.  Contribution of nitric oxide to CpG-mediated protection against Listeria monocytogenes.

Authors:  Shuichi Ito; Ken J Ishii; Atsushi Ihata; Dennis M Klinman
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

2.  Prostaglandin E2 Inhibits the Ability of Neutrophils to Kill Listeria monocytogenes.

Authors:  Michelle G Pitts; Sarah E F D'Orazio
Journal:  J Immunol       Date:  2019-05-06       Impact factor: 5.422

3.  Expression of inducible nitric oxide synthase mRNA and nitric oxide production during the development of liver abscess in hamster inoculated with Entamoeba histolytica.

Authors:  Joel Ramírez-Emiliano; Angélica González-Hernández; Sergio Arias-Negrete
Journal:  Curr Microbiol       Date:  2005-06-13       Impact factor: 2.188

4.  Inhibition of nitric oxide synthase by cobalamins and cobinamides.

Authors:  J Brice Weinberg; Youwei Chen; Ning Jiang; Bethany E Beasley; John C Salerno; Dipak K Ghosh
Journal:  Free Radic Biol Med       Date:  2009-03-27       Impact factor: 7.376

5.  A CpG-containing oligodeoxynucleotide adjuvant for acellular pertussis vaccine improves the protective response against Bordetella pertussis.

Authors:  Catpagavalli Asokanathan; Michael Corbel; Dorothy Xing
Journal:  Hum Vaccin Immunother       Date:  2013-01-04       Impact factor: 3.452

6.  Murine J774 macrophages recognize LPS/IFN-g, non-CpG DNA or two-CpG DNA-containing sequences as immunologically distinct.

Authors:  Lynn Crosby; Warren Casey; Kevin Morgan; Hong Ni; Lawrence Yoon; Marilyn Easton; Mary Misukonis; Gary Burleson; Dipak K Ghosh
Journal:  Nitric Oxide       Date:  2010-01-25       Impact factor: 4.427

7.  CpG oligodeoxynucleotides induce cyclooxygenase-2 in human B lymphocytes: implications for adjuvant activity and antibody production.

Authors:  Matthew P Bernard; Richard P Phipps
Journal:  Clin Immunol       Date:  2007-08-28       Impact factor: 3.969

8.  Regional differences in prostaglandin E2 and nitric oxide production in the knee meniscus in response to dynamic compression.

Authors:  Alfred Hennerbichler; Beverley Fermor; Diana Hennerbichler; J Brice Weinberg; Farshid Guilak
Journal:  Biochem Biophys Res Commun       Date:  2007-05-14       Impact factor: 3.575

9.  Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein by use of CpG oligodeoxynucleotides as an adjuvant induces a protective immune response against an intranasal chlamydial challenge.

Authors:  Sukumar Pal; Heather L Davis; Ellena M Peterson; Luis M de la Maza
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

10.  A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA.

Authors:  Stanimir Ivanov; Ana-Maria Dragoi; Xin Wang; Corrado Dallacosta; Jennifer Louten; Giovanna Musco; Giovanni Sitia; George S Yap; Yinsheng Wan; Christine A Biron; Marco E Bianchi; Haichao Wang; Wen-Ming Chu
Journal:  Blood       Date:  2007-06-04       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.